Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. 4D Molecular Therapeutics Inc shares valued at $8,165 were sold by Bizily Scott on Sep 16 ’24. At $16.33 per share, Bizily Scott sold 500 shares. The insider’s holdings dropped to 6,781 shares worth approximately $37973.6 following the completion of this transaction.
Also, Bizily Scott sold 500 shares, netting a total of over 7,500 in proceeds. Following the sale of shares at $15.00 each, the insider now holds 6,781 shares.
Before that, Bizily Scott had sold 1,750 shares from its account. In a trade valued at $47,442, the Chief Legal Officer traded 4D Molecular Therapeutics Inc shares for $27.11 each. Upon closing the transaction, the insider’s holdings decreased to 1,750 shares, worth approximately $37973.6.
As published in a research note from BMO Capital Markets on January 13, 2025, 4D Molecular Therapeutics Inc [FDMT] has been rated down from an Outperform to a Market perform and the price target has been revised to $15 from $40. Analysts at Morgan Stanley started covering the stock with ‘”an Underweight”‘ outlook in a report released in late November. As of September 23, 2024, Cantor Fitzgerald has decreased its “an Overweight” rating to a “Neutral” for FDMT. Earlier on April 15, 2024, Barclays initiated its rating. Their recommendation was “an Overweight” for FDMT stock.
Analyzing FDMT Stock Performance
During the last five days, there has been a surge of approximately 14.99%. Over the course of the year, 4D Molecular Therapeutics Inc shares have jumped approximately 0.54%. Shares of the company reached a 52-week high of $6.67 on 01/07/25 and a 52-week low of $4.43 on 01/23/25. A 50-day SMA is recorded $6.30, while a 200-day SMA reached $14.82. Nevertheless, trading volume fell to 0.91 million shares from 0.62 million shares the previous day.
Support And Resistance Levels for 4D Molecular Therapeutics Inc (FDMT)
According to the 24-hour chart, there is a support level at 5.16, which, if violated, would cause prices to drop to 4.73. In the upper region, resistance lies at 5.84. The next price resistance is at 6.09. RSI (Relative Strength Index) is 52.39 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.21, which suggests the price will decrease in the coming days. Percent R is at 26.18%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
